Shanghai Fosun Pharmaceutical (Group) (OTCMKTS:SFOSF – Get Free Report) will likely be releasing its results after the market closes on Wednesday, August 26th. Analysts expect Shanghai Fosun Pharmaceutical (Group) to post earnings of $0.0416 per share and revenue of $1.6103 billion for the quarter.
Shanghai Fosun Pharmaceutical (Group) Price Performance
Shares of SFOSF stock opened at $2.20 on Tuesday. Shanghai Fosun Pharmaceutical has a 12 month low of $1.95 and a 12 month high of $3.50. The company has a 50 day simple moving average of $2.11 and a two-hundred day simple moving average of $2.36.
About Shanghai Fosun Pharmaceutical (Group)
Shanghai Fosun Pharmaceutical (Group) Co, Ltd. is a China?based healthcare company and a core subsidiary of Fosun International. The company operates across drug manufacturing, distribution and retail services, and health management. Its product portfolio includes generic and proprietary small?molecule drugs, bio?pharmaceuticals, vaccines and traditional Chinese patent medicines. Through integrated R&D capabilities and strategic partnerships, Fosun Pharmaceutical pursues innovation across therapeutic areas such as oncology, cardiovascular, metabolic and infectious diseases.
The pharmaceutical manufacturing segment encompasses chemical pharmaceuticals, Chinese patent medicines and biological products, while the distribution arm manages one of the largest drug distribution networks in China, supplying hospitals, clinics and retail pharmacies.
Featured Stories
- Five stocks we like better than Shanghai Fosun Pharmaceutical (Group)
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Receive News & Ratings for Shanghai Fosun Pharmaceutical (Group) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shanghai Fosun Pharmaceutical (Group) and related companies with MarketBeat.com's FREE daily email newsletter.
